eglumetad has been researched along with Memory Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballard, TM; Gatti, S; Goetschi, E; Huwyler, J; Knoflach, F; Wichmann, J; Woltering, TJ | 1 |
| Mathis, C; Ungerer, A | 1 |
2 other study(ies) available for eglumetad and Memory Disorders
| Article | Year |
|---|---|
Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 4. In vivo active potent and selective non-competitive metabotropic glutamate receptor 2/3 antagonists.
Topics: Administration, Oral; Animals; Azepines; Behavior, Animal; Benzodiazepinones; Brain; Bridged Bicyclo Compounds; Cholinesterase Inhibitors; Drug Synergism; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Memory Disorders; Rats; Receptors, Metabotropic Glutamate; Scopolamine | 2010 |
The retention deficit induced by (RS)-alpha-methyl-4-carboxyphenylglycine in a lever-press learning task is blocked by selective agonists of either group I or group II metabotropic glutamate receptors.
Topics: Animals; Benzoates; Bridged Bicyclo Compounds; Cycloleucine; Dose-Response Relationship, Drug; Eating; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycine; Learning; Male; Memory Disorders; Mice; Mice, Inbred Strains; Neuroprotective Agents; Protein Isoforms; Receptors, Metabotropic Glutamate; Resorcinols; Retention, Psychology; Time Factors | 1999 |